The results demonstrated that the RGS19 mRNA and protein levels were significantly increased by c-Myc overexpression, while the opposite trend was observed after c-Myc knockdown or 10058-F4 (an inhibitor of c-Myc) treatment in HCC cells (Fig. 6a, b). Here, RGS19 is linked to hepatocellular carcinoma.